Anti-inflammatory cytokines.

@article{Opal2000AntiinflammatoryC,
  title={Anti-inflammatory cytokines.},
  author={Steven Michael Opal and Vera A. DePalo},
  journal={Chest},
  year={2000},
  volume={117 4},
  pages={
          1162-72
        }
}
The anti-inflammatory cytokines are a series of immunoregulatory molecules that control the proinflammatory cytokine response. Cytokines act in concert with specific cytokine inhibitors and soluble cytokine receptors to regulate the human immune response. Their physiologic role in inflammation and pathologic role in systemic inflammatory states are increasingly recognized. Major anti-inflammatory cytokines include interleukin (IL)-1 receptor antagonist, IL-4, IL-6, IL-10, IL-11, and IL-13… 

Figures and Tables from this paper

Pro- and Anti-inflammatory Cytokines in Visceral Leishmaniasis

Visceral leishmaniasis is a vector borne disease caused by Leishmania donovani complex, and its immunopathogenesis is not well understood, however, IL-10 is widely accepted as an immunosuppressive cytokine involved in the pathogenesis.

Pro- and Anti-inflammatory Cytokines in Visceral Leishmaniasis

Visceral leishmaniasis is a vector borne disease caused by Leishmania donovani complex, and its immunopathogenesis is not well understood, however, IL-10 is widely accepted as an immunosuppressive cytokine involved in the pathogenesis.

Pediatric Sepsis Markers: Interleukins and Others

High levels of some cytokines, such as tumor necrosis factor-α, interleukin (IL)-1, and IL-6, determine the course of disease and outcome in sepsis, and numerous other biomarkers may be potential indicators of sepsi, but none has been routinely used.

Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes.

  • M. BanerjeeM. Saxena
  • Biology, Medicine
    Clinica chimica acta; international journal of clinical chemistry
  • 2012

Present Concepts on the Inflammatory Modulators with Special Reference to Cytokines*

  • A. V. Miert
  • Biology
    Veterinary Research Communications
  • 2004
This review highlights new developments in the understanding of the pathophysiology of inflammation and gives an example of a more recent approach to the modulation of acute systemic inflammatory disorders: activation of β2-adrenergic receptors on macrophages.

Regulation of chemokine expression by antiinflammatory cytokines

Mechanisms through which IL-10 and IL-4 acttodampen inflammatory responses are mechanistically distinct and involve diverse intracellular signaling pathways.

Constitutive Inflammatory Cytokine Storm: A Major Threat to Human Health.

  • K. GuptaMohd Aqueel KhanS. Singh
  • Biology, Medicine
    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
  • 2019
The regulators of cytokine release, its types, its implications on human health, and treatment are discussed.

Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor β on cancer cells

The influence of IL-10, IL-4 and TGF-β on various types of cancer as well as potential of these selected cytokines to serve as new biomarkers which can support effective therapies for cancer patients are focused on.

Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation.

Findings indicate that SOCS-1 is critical in both T cells and macrophages for preventing uncontrolled inflammation.

IL-19 Induces Production of IL-6 and TNF-α and Results in Cell Apoptosis Through TNF-α1

The results indicate that mouse IL-19 may play some important roles in inflammatory responses because it up-regulates IL-6 and TNF-α and induces apoptosis.
...

References

SHOWING 1-10 OF 116 REFERENCES

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

The studies reveal that endogenous IL-6 plays a crucial antiinflammatory role in both local and systemic acute inflammatory responses by controlling the level of proinflammatory, but not antiinflammatory, cytokines, and that these antiinflammatory activities byIL-6 cannot be compensated for by IL-10 or other IL- 6 family members.

Interleukin-10: potential benefits and possible risks in clinical infectious diseases.

  • S. OpalJ. WherryP. Grint
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1998
Carefully selected patients with inflammatory conditions may benefit from IL-10 therapy if concomitant infectious diseases are recognized and treated appropriately.

Induction of interleukin-1 and interleukin-1 receptor antagonist.

Interferon-alpha2b is a potent inhibitor in vitro of the induction of IL-1 and tumor necrosis factor by IL- 1 and can induce high circulating levels of the anti-inflammatory soluble tumor Necrosis factor receptor andIL-1 receptor antagonist in humans.

Induction of interleukin-1 and interleukin-1 receptor antagonist.

Interferon-alpha2b is a potent inhibitor in vitro of the induction of IL-1 and tumor necrosis factor by IL- 1 and can induce high circulating levels of the anti-inflammatory soluble tumor Necrosis factor receptor andIL-1 receptor antagonist in humans.

Anti-inflammatory cytokine levels in patients with septic shock.

  • T. KasaiK. Inada S. Endo
  • Medicine, Biology
    Research communications in molecular pathology and pharmacology
  • 1997
The plasma levels of IL-1ra and IL-10 were elevated in the septic shock group compared with the sepsis group and the elevated levels of TNFR I and TNFR II appeared to reflect an attempt to suppress the shock syndrome.

Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.

IL-4 can suppress some parameters of monocyte activation and, as for B cells, have opposite effects to IFN-gamma, and the effects of IL-4 on human monocytes are similar to those obtained with the glucocorticoid dexamethasone.

IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB.

The results suggest that the anti-inflammatory activity of rhIL-11 is mediated in part by inhibition of NF-kappaB-dependent transcriptional activation, and for the first time the regulation of Ikappa B-beta by an anti- inflammatory cytokine is demonstrated.

Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis.

IL-11 has important endogenous immunoregulatory effects in RA synovium, which suggests that exogenous IL-11 may have therapeutic activity in RA.

Regulation of acute lung inflammatory injury by endogenous IL-13.

It is suggested that during lung inflammation endogenous IL-13 regulates NF-kappaB activation and related cytokine/chemokine generation, all of which determines the intensity of the lung inflammatory response.

Biologic basis for interleukin-1 in disease.

This is a lengthy review, with 586 citations chosen to illustrate specific areas of interest rather than a compendium of references, which summarizes what the author considers established or controversial topics linking the biology of IL-1 to mechanisms of disease.
...